PMID- 37286361 OWN - NLM STAT- MEDLINE DCOM- 20230927 LR - 20240201 IS - 1526-632X (Electronic) IS - 0028-3878 (Print) IS - 0028-3878 (Linking) VI - 101 IP - 13 DP - 2023 Sep 26 TI - Impact of Seizures While Driving Prior to Diagnosis in People With Focal Epilepsy: Motor Vehicle Accidents and Time to Diagnosis. PG - e1370-e1375 LID - 10.1212/WNL.0000000000207464 [doi] AB - OBJECTIVES: To identify the type, frequency, and consequences of seizures while driving (SzWD) in people with epilepsy before diagnosis. METHODS: We performed a retrospective cohort study using the Human Epilepsy Project (HEP) to identify prediagnostic SzWD. Clinical descriptions from seizure diaries and medical records were used to classify seizure types and frequencies, time to diagnosis, and SzWD outcomes. Data were modeled using multiple logistic regression to assess for factors independently associated with SzWD. RESULTS: 32 prediagnostic SzWD were reported among 23/447 (5.1%) participants. Of them, 7 (30.4%) had more than 1. Six participants (26.1%) experienced SzWD as their first lifetime seizure. Most SzWD were focal with impaired awareness (n = 27, 84.4%). Of participants who had motor vehicle accidents (MVAs), 6 (42.9%) had no recollection. SzWD led to hospitalization in 11 people. The median time from first seizure to first SzWD was 304 days (IQR = 0-4,056 days). The median time between first SzWD and diagnosis was 64 days (IQR = 10-176.5 days). Employment was associated with a 3.95-fold increased risk of SzWD (95% CI 1.2-13.2, p = 0.03), and nonmotor seizures were associated with a 4.79-fold increased risk (95% CI 1.3-17.6, p = 0.02). DISCUSSION: This study identifies the consequences of seizure-related MVAs and hospitalizations people experience before epilepsy diagnosis. This highlights the need for further research aimed at improving seizure awareness and improving time to diagnosis. CI - (c) 2023 American Academy of Neurology. FAU - Bases, Benjamin AU - Bases B AD - From the Tulane University Undergraduate School of Public Health and Tropical Medicine (B.B.), New Orleans, LA; Monash University School of Medicine (S.B.), Clayton, Australia; Department of Neurology (J.A.F.), NYU Langone Health, New York; and Department of Neurology (J.P.), University of Colorado School of Medicine, Aurora. FAU - Barnard, Sarah AU - Barnard S AD - From the Tulane University Undergraduate School of Public Health and Tropical Medicine (B.B.), New Orleans, LA; Monash University School of Medicine (S.B.), Clayton, Australia; Department of Neurology (J.A.F.), NYU Langone Health, New York; and Department of Neurology (J.P.), University of Colorado School of Medicine, Aurora. FAU - French, Jacqueline A AU - French JA AUID- ORCID: 0000-0002-8756-6546 AD - From the Tulane University Undergraduate School of Public Health and Tropical Medicine (B.B.), New Orleans, LA; Monash University School of Medicine (S.B.), Clayton, Australia; Department of Neurology (J.A.F.), NYU Langone Health, New York; and Department of Neurology (J.P.), University of Colorado School of Medicine, Aurora. FAU - Pellinen, Jacob AU - Pellinen J AUID- ORCID: 0000-0002-0747-7210 AD - From the Tulane University Undergraduate School of Public Health and Tropical Medicine (B.B.), New Orleans, LA; Monash University School of Medicine (S.B.), Clayton, Australia; Department of Neurology (J.A.F.), NYU Langone Health, New York; and Department of Neurology (J.P.), University of Colorado School of Medicine, Aurora. jacob.pellinen@cuanschutz.edu. CN - Human Epilepsy Project LA - eng GR - UL1 TR002535/TR/NCATS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20230607 PL - United States TA - Neurology JT - Neurology JID - 0401060 RN - 0 (Anticonvulsants) SB - IM MH - Humans MH - Anticonvulsants/therapeutic use MH - Retrospective Studies MH - Seizures/diagnosis/epidemiology/chemically induced MH - *Epilepsies, Partial/diagnosis/drug therapy MH - *Epilepsy/drug therapy MH - Accidents, Traffic MH - Motor Vehicles PMC - PMC10558166 COIS- B. Bases and S. Barnard report no disclosures relevant to this article; J. French receives salary support from the Epilepsy Foundation and for consulting work and/or attending Scientific Advisory Boards on behalf of the Epilepsy Study Consortium for Aeonian/Aeovian, Alterity Therapeutics Limited, Anavex, Arkin Holdings, Angelini Pharma S.p.A, Arvelle Therapeutics, Inc., Athenen Therapeutics/Carnot Pharma, Autifony Therapeutics Limited, Baergic Bio, Biogen, Biohaven Pharmaceuticals, BioMarin Pharmaceutical Inc., BioXcel Therapeutics, Bloom Science Inc., BridgeBio Pharma Inc., Camp4 Therapeutics Corporation, Cerebral Therapeutics, Cerevel, Clinical Education Alliance, Coda Biotherapeutics, Corlieve Therapeutics, Crossject, Eisai, Eliem Therapeutics, Encoded Therapeutics, Engage Therapeutics, Engrail, Epalex, Epihunter, Epiminder, Epitel Inc, Equilibre BioPharmaceuticals, Greenwich Biosciences, Grin Therapeutics, GW Pharma, Janssen Pharmaceutica, Jazz Pharmaceuticals, Knopp Biosciences, Lipocine, LivaNova, Longboard Pharmaceuticals, Lundbeck, Marinus, Mend Neuroscience, Merck, NeuCyte Inc., Neumirna Therapeutics, Neurocrine, Neuroelectrics USA Corporation, Neuronetics Inc., Neuropace, NxGen Medicine Inc., Ono Pharmaceutical Co., Otsuka Pharmaceutical Development, Ovid Therapeutics Inc., Paladin Labs Inc., Passage Bio, Pfizer, Praxis, PureTech LTY Inc., Rafa Laboratories Ltd, SK Life Sciences, Sofinnova, Stoke, Supernus, Synergia Medical, Takeda, UCB Inc., Ventus Therapeutics, Xenon, Xeris, Zogenix, and Zynerba. J. French has also received research support from the Epilepsy Study Consortium (Funded by Andrews Foundation, Eisai, Engage, Lundbeck, Pfizer, SK Life Science, Sunovion, UCB, Vogelstein Foundation) Epilepsy Study Consortium/Epilepsy Foundation (funded by UCB), GW/FACES, and NINDS. J. French is on the editorial board of Lancet Neurology and Neurology Today. J. French is the Chief Medical/Innovation Officer for the Epilepsy Foundation. J. French has received travel reimbursement related to research, advisory meetings, or presentation of results at scientific meetings from the Epilepsy Study Consortium, the Epilepsy Foundation, Angelini Pharma S.p.A., Clinical Education Alliance, NeuCyte, Inc., Neurocrine, Praxis, and Xenon. J. Pellinen has received research support from the Department of Neurology at the University of Colorado School of Medicine, the Colorado Clinical and Translational Sciences Institute by way of NIH/NCATS Colorado CTSA Grant Number UL1 TR002535, NIH/NINDS in the form of a Clinical Research LRP, and the American Epilepsy Society. J. Pellinen serves as chair of the professional advisory board for the Epilepsy Foundation of Colorado and Wyoming (unpaid), serves as the Epilepsy Section Editor for Current Neurology and Neuroscience Reports, and has received compensation for advisory board work for SK Life Science. Go to Neurology.org/N for full disclosures. FIR - Kuzniecky, Ruben IR - Kuzniecky R FIR - Lowenstein, Daniel IR - Lowenstein D FIR - Cristofaro, Sabrina IR - Cristofaro S FIR - McKenna, Kevin IR - McKenna K FIR - Mays, Vickie IR - Mays V FIR - Shack, Darrell IR - Shack D FIR - Barnard, Sarah IR - Barnard S FIR - Burke, Cheryl IR - Burke C FIR - Hegde, Manu IR - Hegde M FIR - Glauser, Tracy IR - Glauser T FIR - O'Brien, Terence IR - O'Brien T FIR - Pollard, John IR - Pollard J FIR - Ting, Tricia IR - Ting T FIR - Meador, Kimford IR - Meador K FIR - Morrison, Chris IR - Morrison C FIR - Penovich, Patricia IR - Penovich P FIR - Henninger, Heidi IR - Henninger H FIR - Scavo, Vernonica IR - Scavo V FIR - Darby, David IR - Darby D FIR - Kanner, Andres IR - Kanner A FIR - Altalib, Hamada Hamid IR - Altalib HH FIR - Barry, John IR - Barry J FIR - Hesdorffer, Dale IR - Hesdorffer D FIR - Hope, Omotola IR - Hope O FIR - Nadkarni, Siddhartha IR - Nadkarni S FIR - Sperling, Michael IR - Sperling M FIR - Winawer, Melodie IR - Winawer M FIR - Dlugos, Dennis IR - Dlugos D FIR - Beal, Jules IR - Beal J FIR - Boro, Alexis IR - Boro A FIR - Herman, Susan IR - Herman S FIR - Singh, Rani IR - Singh R FIR - Halford, John IR - Halford J FIR - Bergey, Gregory IR - Bergey G FIR - Geller, Eric IR - Geller E FIR - Gloss, David IR - Gloss D FIR - Singh, Rani IR - Singh R FIR - Worrell, Gregory IR - Worrell G FIR - Thio, Liu Lin IR - Thio LL FIR - Pardoe, Heath IR - Pardoe H FIR - Cascino, Gregory D IR - Cascino GD FIR - Glynn, Simon IR - Glynn S FIR - Jackson, Graeme IR - Jackson G FIR - Knowlton, Robert IR - Knowlton R FIR - Szaflarski, Jerzy IR - Szaflarski J FIR - Gidal, Barry IR - Gidal B FIR - Abou-Khalil, Bassel IR - Abou-Khalil B FIR - Alldredge, Brian IR - Alldredge B FIR - Faught, Edward IR - Faught E FIR - Ficker, David IR - Ficker D FIR - Klein, Pavel IR - Klein P FIR - Mintzer, Scott IR - Mintzer S FIR - Cloyd, James IR - Cloyd J FIR - Holmes, Manisha IR - Holmes M FIR - Detyniecki, Kamil IR - Detyniecki K FIR - Haut, Sheryl IR - Haut S FIR - Hixson, John IR - Hixson J FIR - Kalviainen, Reetta IR - Kalviainen R FIR - Widdess-Walsh, Peter IR - Widdess-Walsh P FIR - Krishnamurthy, Kaarkuzhali IR - Krishnamurthy K FIR - Park, Kristen IR - Park K FIR - Gelfand, Michael IR - Gelfand M FIR - Kang, Joon IR - Kang J FIR - Krauss, Gregory IR - Krauss G FIR - Cole, Andrew IR - Cole A FIR - Halford, Jonathan IR - Halford J FIR - Atkinson, Paul IR - Atkinson P FIR - Trinka, Eugen IR - Trinka E FIR - Kirschner, Margarita IR - Kirschner M FIR - Schmid, Elisabeth IR - Schmid E FIR - Somerville, Ernest IR - Somerville E FIR - Zentner, Christian IR - Zentner C FIR - Laue-Gizzi, Hanka IR - Laue-Gizzi H FIR - Rodriguez, Andy IR - Rodriguez A FIR - Devinsky, Orrin IR - Devinsky O FIR - Nadkarni, Mangala IR - Nadkarni M FIR - Cook, Mark IR - Cook M FIR - Berkovic, Sam IR - Berkovic S FIR - Bebin, Martina IR - Bebin M FIR - Szabo, Charles IR - Szabo C FIR - Burneo, Jorge IR - Burneo J FIR - Weisenberg, Judy IR - Weisenberg J FIR - Lu, Charles IR - Lu C FIR - Michel, George IR - Michel G FIR - Baig, Mirza IR - Baig M FIR - Cutter, Gary IR - Cutter G EDAT- 2023/06/08 01:08 MHDA- 2023/09/27 06:43 PMCR- 2024/09/26 CRDT- 2023/06/07 21:37 PHST- 2022/12/20 00:00 [received] PHST- 2023/04/13 00:00 [accepted] PHST- 2024/09/26 00:00 [pmc-release] PHST- 2023/09/27 06:43 [medline] PHST- 2023/06/08 01:08 [pubmed] PHST- 2023/06/07 21:37 [entrez] AID - WNL.0000000000207464 [pii] AID - WNL-2023-000297 [pii] AID - 10.1212/WNL.0000000000207464 [doi] PST - ppublish SO - Neurology. 2023 Sep 26;101(13):e1370-e1375. doi: 10.1212/WNL.0000000000207464. Epub 2023 Jun 7.